Understanding symptom clusters, diagnosis and healthcare experiences in myalgic encephalomyelitis/chronic fatigue syndrome and long COVID: a cross-sectional survey in the UK. — CFSMEATLAS
Understanding symptom clusters, diagnosis and healthcare experiences in myalgic encephalomyelitis/chronic fatigue syndrome and long COVID: a cross-sectional survey in the UK.
Mansoubi, Maedeh, Richards, Thomas, Ainsworth-Wells, Martine et al. · BMJ open · 2025 · DOI
Quick Summary
This large UK survey asked over 8,800 people with ME/CFS or long COVID about their symptoms and experiences with healthcare. The study found that fatigue, brain fog, pain, and sleep problems are the most common symptoms, but people often wait years for a diagnosis. Even after new healthcare guidelines were introduced, most patients said they weren't satisfied with the care they received from the NHS.
Why It Matters
This study provides robust evidence that ME/CFS patients face prolonged diagnostic delays and significant dissatisfaction with NHS services despite recent guideline updates, highlighting a critical gap between policy and practice. The findings validate the common experience of patients struggling to access appropriate care and support the need for systemic improvements in diagnosis, recognition, and management within the health system.
Observed Findings
Cognitive dysfunction (88.4%) and fatigue (88.2%) were the most commonly reported symptoms, appearing in nearly 9 in 10 participants
Postexertional malaise affected 78.2% of participants, showing it is nearly universal in ME/CFS populations
Diagnostic timelines varied dramatically: some waited over 10 years (12.9%) while others were diagnosed within 1-2 years (22.1%)
Only 10.1% of participants felt that updated NICE guidelines had a positive impact on their care
NHS satisfaction was markedly low at 6.9% for ME/CFS and 14.4% for long COVID patients
Inferred Conclusions
ME/CFS and long COVID share a core symptom profile of fatigue, cognitive dysfunction, pain, and sleep disturbance, but diagnostic recognition remains poor
Significant gaps exist between published healthcare guidelines and actual patient experience, suggesting implementation failures or inadequate resources
Current NHS service provision is insufficient to meet patient needs, requiring improved self-management resources and better-coordinated specialist care
Diagnostic delays remain a major problem despite increased awareness, indicating systemic barriers to recognition and referral
Remaining Questions
What specific barriers prevent NHS implementation of NICE guidelines, and why do only 10% of patients perceive benefit from them?
What This Study Does Not Prove
This cross-sectional survey cannot determine whether diagnostic delays cause worse outcomes or whether low satisfaction is due to guideline implementation failures versus other healthcare system factors. The study identifies what patients report but does not prove causation between NICE guidelines and clinical practice changes, nor does it establish why symptom clusters exist or their underlying biological mechanisms.